Metsera, Inc. — Investor Relations & Filings
Metsera, Inc. is a clinical-stage biopharmaceutical company focused on developing next-generation medicines for obesity and related metabolic diseases. The company's portfolio includes both injectable and oral therapeutic candidates based on nutrient-stimulated hormone (NuSH) analog peptides. Leveraging a proprietary peptide engineering platform, Metsera aims to create potent, ultra-long-acting therapies with improved durability, bioavailability, and manufacturability. The company's approach is designed to deliver scalable treatments, including oral options with injectable-like performance, to enhance effectiveness, tolerability, and long-term patient adherence.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| SCHEDULE 13G/A Filing | 2026-02-17 | English | |
| 15-12G | 2025-11-24 | English | |
| Major Shareholding Notification 2025 | 2025-11-17 | English | |
| 4 | 2025-11-17 | English | |
| STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 2025-11-14 | English | |
| Major Shareholding Notification 2025 | 2025-11-14 | English |
Browse filings by year
3 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
1 filing
| |||||
| 32333724 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
|
2025
14 filings
| |||||
| 13718408 | 15-12G | 2025-11-24 | English | ||
| 13718409 | Major Shareholding Notification 2025 | 2025-11-17 | English | ||
| 13718410 | 4 | 2025-11-17 | English | ||
| 13718411 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 2025-11-14 | English | ||
| 13718412 | Major Shareholding Notification 2025 | 2025-11-14 | English | ||
| 13718413 | Major Shareholding Notification 2025 | 2025-11-13 | English | ||
| 13718414 | 4 | 2025-11-13 | English | ||
| 13718415 | 4 | 2025-11-13 | English | ||
| 13718417 | 4 | 2025-11-13 | English | ||
| 13718416 | 4 | 2025-11-13 | English | ||
| 13718419 | 4 | 2025-11-13 | English | ||
| 13718418 | 4 | 2025-11-13 | English | ||
| 13718420 | 4 | 2025-11-13 | English | ||
| 13718421 | 4 | 2025-11-13 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AFC-HD AMS Life Science Co.,Ltd.
An OEM of health foods, supplements, and cosmetics with int…
|
2927 | JP | Manufacturing |
|
Afexa Life Sciences Inc.
Researched, developed, and manufactured naturally derived O…
|
FXA | CA | Manufacturing |
|
AFT Pharmaceuticals Limited
Develops, licenses, and distributes pharmaceuticals across …
|
AFT | NZ | Manufacturing |
|
AFT PHARMACEUTICALS LIMITED
Develops and licenses healthcare products for pain manageme…
|
AFP | AU | Manufacturing |
|
AGENUS INC
A clinical-stage biotechnology company specializing in immu…
|
AGEN | US | Manufacturing |
|
AGIOS PHARMACEUTICALS, INC.
Biopharmaceutical company developing therapies for rare and…
|
AGIO | US | Manufacturing |
|
AGP Limited
Pharmaceutical company manufacturing, marketing, and distri…
|
AGP | PK | Manufacturing |
|
AHN-GOOK PHARMACEUTICAL Co., Ltd.
Develops and markets medicines, focusing on respiratory and…
|
001540 | KR | Manufacturing |
|
AIM Vaccine Co., Ltd.
Develops, manufactures, and commercializes established and …
|
6660 | HK | Manufacturing |
|
AION THERAPEUTIC INC.
Health and wellness company developing AI-driven bio-pharma…
|
AION | CA | Manufacturing |
Metsera, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/30975/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=30975 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=30975 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=30975 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 30975}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Metsera, Inc. (id: 30975)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.